NDC 0093-4137 – Cefdinir
Cefdinir Monohydrate 250 mg/5mL · Powder, For Suspension · Oral
Product NDC0093-4137
Product details
- Brand name
- Cefdinir
- Generic name
- Cefdinir
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- Powder, For Suspension
- Route
- Oral
- Marketing category
- ANDA · ANDA065332
- Marketed since
- May 8, 2007
- Listing expires
- December 31, 2026
- Pharmacologic class
- Cephalosporin Antibacterial
Active ingredients
- Cefdinir Monohydrate 250 mg/5mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0093-4137-64 | 60 mL in 1 BOTTLE (0093-4137-64) | May 8, 2007 |
| 0093-4137-73 | 100 mL in 1 BOTTLE (0093-4137-73) | May 8, 2007 |
Recalls mentioning this NDC
- D-247-2013 Apr 17, 2013 · Class II
Defective Container: This recall is being carried out due to the potential for improperly sealed bottles.
Other Cefdinir products
- 50090-5811 Cefdinir 250 mg/5mL · Powder, For Suspension · A-S Medication Solutions
- 50090-6417 Cefdinir 125 mg/5mL · Powder, For Suspension · A-S Medication Solutions
- 50090-7929 Cefdinir 125 mg/5mL · Powder, For Suspension · A-S Medication Solutions
- 50090-6171 Cefdinir 250 mg/5mL · Powder, For Suspension · A-S Medication Solutions
- 50090-2735 Cefdinir 250 mg/5mL · Powder, For Suspension · A-S Medication Solutions
- 50090-3723 Cefdinir 250 mg/5mL · Powder, For Suspension · A-S Medication Solutions
- 50090-3725 Cefdinir Monohydrate 250 mg/5mL · Powder, For Suspension · A-S Medication Solutions
- 50090-4258 Cefdinir 125 mg/5mL · Powder, For Suspension · A-S Medication Solutions
- 67877-547 Cefdinir 125 mg/5mL · Powder, For Suspension · Ascend Laboratories, LLC
- 67877-548 Cefdinir 250 mg/5mL · Powder, For Suspension · Ascend Laboratories, LLC
- 76420-328 Cefdinir 250 mg/5mL · Powder, For Suspension · Asclemed USA, Inc.
- 76420-327 Cefdinir 125 mg/5mL · Powder, For Suspension · Asclemed USA, Inc.